AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange AquaBounty Technologies stocks are traded under the ticker W8NB.MU.
When is the next AquaBounty Technologies earnings date?▼
AquaBounty Technologies is going to release the next earnings report on August 11, 2026.
How many employees does AquaBounty Technologies have?▼
As of July 10, 2026, the company has 4 employees.
In which sector is AquaBounty Technologies located?▼
AquaBounty Technologies operates in the Health & Wellness sector.
When did AquaBounty Technologies complete a stock split?▼
AquaBounty Technologies has not had any recent stock splits.
Where is AquaBounty Technologies headquartered?▼
AquaBounty Technologies is headquartered in Harvard, United States.